LITERATURE · PEER REVIEWED

Crystal structure of the human histone methyltransferase ASH1L catalytic domain and its implications for the regulatory mechanism

Journal of Biological Chemistry · 2011 · Peer reviewed

COMPLETE CITATION

Citation and identifiers

An S, Yeo KJ, Jeon YH, Song JJ. “Crystal structure of the human histone methyltransferase ASH1L catalytic domain and its implications for the regulatory mechanism.” Journal of Biological Chemistry. 286(10):8369–8374 · doi:10.1074/jbc.M110.203380.

PubMed ID
21239497

RESEARCH QUESTION

What structural feature of the human ASH1L catalytic domain explains its autoinhibited state?

The catalytic-domain crystal structure identifies a substrate-blocking autoinhibitory loop but cannot assign cell-type effects or the consequences of clinical variants.

INTERPRETATION BOUNDARY

Read the finding and limit together.

What this study supports

Foundational catalytic-domain structure demonstrating an autoinhibitory loop that blocks substrate access in the inactive state.

What it cannot establish

Purified catalytic-domain structure does not define cell-type phenotype or clinical variant effect.

OPEN THE STUDY